Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Since April 2020, the S&P 500 has delivered a total return of 90.9%. But one standout stock has nearly doubled the market - over the past five years, Option Care Health has surged 173% to $33.19 per share. Its momentum hasn’t stopped as it’s also gained 8.8% in the last six months thanks to its solid quarterly results, beating the S&P by 19.5%.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (NYSE:CHE) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at The Pennant Group (NASDAQ:PNTG) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at senior health, home health & hospice stocks, starting with Addus HomeCare (NASDAQ:ADUS).
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Brookdale (NYSE:BKD) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services (NYSE:AMN) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BrightSpring Health Services (NASDAQ:BTSG) and its peers.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including McKesson (NYSE:MCK) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Cardinal Health (NYSE:CAH) and the best and worst performers in the healthcare providers & services industry.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including Pediatrix Medical Group (NYSE:MD) and its peers.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 11.2%. This drawdown was much worse than the S&P 500’s 1.1% decline.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including The Ensign Group (NASDAQ:ENSG) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including AdaptHealth (NASDAQ:AHCO) and its peers.
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges.
However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG)
will be announcing earnings results tomorrow before market open. Here’s what to expect.
Alternate site health provider Option Care Health (NASDAQ:OPCH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.4 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $0.44 per share was 21.4% above analysts’ consensus estimates.
